ProMIS Neurosciences, Inc. (PMN)

11.01 -0.03 (-0.27%) USD  |  NASDAQ  |  May 01, 16:00
11.09 +0.08 (+0.73%) After-Hours: 20:00
More

ProMIS Neurosciences Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for PMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. --
Lexaria Bioscience Corp. Upgrade
Sirona Biochem Corp. --
Xenon Pharmaceuticals, Inc. Upgrade